Dental medicinal membrane and preparation method thereof

A medicine film and oral cavity technology, applied in the field of medicine preparation, can solve the problems of slow curative effect, difficult promotion, inability to heal ulcers quickly and effectively, and achieve the effects of low cost, simple preparation method and remarkable therapeutic effect.

Inactive Publication Date: 2014-07-16
QINGDAO MUNICIPAL HOSPITAL
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Various powders for external use currently on the market have slow curative effects and cannot heal ulcers quickly and effectively
[0003]There are many factors that cause oral ulcers, such as oral ulcers caused by excessive fatigue; internal factors such as endocrine disorders and decreased autoimmunity; genetic factors, high mental pressure, work External factors such as fatigue and frequent insomnia; some people also believe that oral ulcers are directly related to genetics, hormones and other factors. For example, oral ulcers in women tend to worsen before menstruation, and menopausal women are more likely to suffer from oral ulcers, but pregnant women It is not easy to suffer from oral ulcers. These phenomena all show that the occurrence of ulcers is directly related to the changes in hormone levels in the body; although many methods for treating oral ulcers have many advantages, some shortcomings will lead to difficulties in clinical promotion. For example, the application of rhG -GSF saline in the treatment of oral ulcers caused by chemotherapy drugs, although the curative effect is obvious, but due to the high price of rhG-CSF drugs, it is very difficult for poor families to pay for disease chemotherapy, and it is impossible for them to spend expensive The price is to buy rhG-CSF separately for mouthwash, so the high cost of the treatment method is also a limiting factor for clinical promotion

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] An oral medicine film comprising the following components:

[0019] Clotrimazole 5g; dyclonine 5g; metronidazole 2g; dexamethasone 0.5g; CMC-Na 15g; sodium alginate 50g; tragacanth gum 15g; ethanol 120g; purified water 1300g.

[0020] The preparation of the above-mentioned oral film includes the following steps:

[0021] (1) Soak the sodium alginate with ethanol and grind it in a mortar for later use;

[0022] (2) Take tragacanth gum and CMC-Na, add purified water to peptize naturally;

[0023] (3) Dissolve clotrimazole and dyclonine with ethanol, and slowly add the dissolving solution to the mortar of step (1), and dissolve dexamethasone and metronidazole in purified water with step ( 2) After the solution in step (1) is mixed, slowly add it to the mortar of step (1) and grind continuously to obtain a glue solution;

[0024] (4) The glue solution is made into a film, dried, and then divided into bags.

Embodiment 2

[0026] An oral medicine film comprising the following components:

[0027] Clotrimazole 8g; dyclonine 8g; metronidazole 3g; dexamethasone 0.6g; CMC-Na18g; sodium alginate 60g; tragacanth gum 18g; ethanol 150g; purified water 1500g.

[0028] The preparation of the above-mentioned oral medicine film is as follows:

[0029] (1) Soak the sodium alginate with ethanol and grind it in a mortar for later use;

[0030] (2) Take tragacanth gum and CMC-Na, add purified water to peptize naturally;

[0031] (3) Dissolve clotrimazole and dyclonine with ethanol, and slowly add the dissolving solution to the mortar of step (1), and dissolve dexamethasone and metronidazole in purified water with step ( 2) After the solution in step (1) is mixed, slowly add it to the mortar of step (1) and grind continuously to obtain a glue solution;

[0032] (4) The glue solution is made into a film, dried, and then divided into bags.

Embodiment 3

[0034] An oral medicine film comprising the following components:

[0035] Clotrimazole 3g; Dyclonine 3g; Metronidazole 1g; Dexamethasone 0.3-g; CMC-Na 10g; Sodium Alginate 40g; Tragacanth Gum 12g; Ethanol 100g; Purified Water 1000g.

[0036] The preparation of the above-mentioned oral medicine film includes the following steps:

[0037] (1) Soak the sodium alginate with ethanol and grind it in a mortar for later use;

[0038] (2) Take tragacanth gum and CMC-Na, add purified water to peptize naturally;

[0039] (3) Dissolve clotrimazole and dyclonine with ethanol, and slowly add the dissolving solution to the mortar of step (1), and dissolve dexamethasone and metronidazole in purified water with step ( 2) After the solution in step (1) is mixed, slowly add it to the mortar of step (1) and grind continuously to obtain a glue solution;

[0040] (4) The glue solution is made into a film, dried, and then divided into bags.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a dental medicinal membrane. The dental medicinal membrane comprises the following components by weight: 3-8g of clotrimazole, 3-8g of dyclonine, 1-3g of metronidazole, 0.3-0.6g of dexamethasone, 10-18g of CMC-Na (sodium carboxymethylcellulose), 40-60g of sodium alginate, 12-18g of tragacanth, 100-150g of ethanol and 1,000-1,500g of purified water. The invention also provides preparation of the dental medicinal membrane, which comprises the following steps: (1) soaking the sodium alginate with ethanol, and grinding in a mortar for later use; (2) naturally peptizing the tragacanth and CMC-Na in the purified water; (3) dissolving the clotrimazole and metronidazole in ethanol, and slowly adding the solution into the mortar in the step (1); dissolving the dexamethasone and metronidazole in the purified water, mixing with the solution in the step (2), slowly adding the mixture into the mortar in the step (1), and constantly grinding to obtain a colloidal liquid; and (4) preparing a membrane from the colloidal liquid, drying and subpackaging. The dental medicinal membrane is low in cost, simple in preparation method and remarkable in treatment effect, and has the effects of inhibiting bacteria and diminishing inflammation; and the dental medicinal membrane is an external application, and is applied to an affected part.

Description

technical field [0001] The invention relates to an oral medicine film and a preparation method thereof, belonging to the technical field of medicine preparation. Background technique [0002] Oral ulcer, also known as "oral sore", is a disease of the department of stomatology. The size can range from rice grains to soybeans, and it is round or oval. The ulcer surface is concave and the surrounding is congested. Ulcers have the characteristics of periodicity, recurrence and self-limitation, and are prone to occur on the lips, cheeks, and tongue margins. With the prolongation of the course of the disease, many patients have enlarged ulcer area and number, aggravated pain, prolonged healing period, and shortened interval, which affect eating and speaking. Various powders for external use currently sold in the market have a slow curative effect and cannot heal ulcers quickly and effectively. [0003] There are many factors that cause oral ulcers, such as oral ulcers caused by ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/573A61K9/70A61P1/02A61P31/04A61P29/00A61K31/4453A61K31/4174A61K31/4164
Inventor 李志平刘华强王黎
Owner QINGDAO MUNICIPAL HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products